Skip Navigation


IJE Advance Access originally published online on July 17, 2006
International Journal of Epidemiology 2006 35(5):1329-1330; doi:10.1093/ije/dyl156
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
35/5/1329    most recent
dyl156v2
dyl156v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Eholié, S.
Right arrow Articles by Anglaret, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eholié, S.
Right arrow Articles by Anglaret, X.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2006; all rights reserved.

Commentary

Commentary: Decline of HIV-2 prevalence in West Africa: good news or bad news?

Serge Eholié1 and Xavier Anglaret2,*

1 Service des maladies infectieuses et tropicales CHU de Treichville, Abidjan, Côte d'Ivoire
2 INSERM U593, Université Bordeaux 2, Bordeaux, France

* Corresponding author. E-mail: Xavier.Anglaret@isped.u-bordeaux2.fr

The first 10% of the full text of this article appears below.

The HIV pandemic is a continuing global health emergency. At the end of 2005, WHO and UNAIDS estimated that ~40 million people are infected with HIV, with >60% of infections affecting people living in sub-Saharan Africa. The pandemic is very much dominated by infections with HIV type 1 (HIV-1), which was discovered in 1983. In 1987, a second type of virus was identified: HIV type 2 (HIV-2). It rapidly became clear that the epidemic of HIV-2 is limited to relatively few areas, mainly in the Portuguese-speaking part of . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
M. L. Ntemgwa, T. d. Toni, B. G. Brenner, R. J. Camacho, and M. A. Wainberg
Antiretroviral Drug Resistance in Human Immunodeficiency Virus Type 2
Antimicrob. Agents Chemother., September 1, 2009; 53(9): 3611 - 3619.
[Full Text] [PDF]